glp-1 drugs news The promises and pitfalls of GLP-1 drugs like Ozempic linked

Yet subcutaneous injections of recombinant GLP-1 were a disappointment in patients, falling short of prior results with intravenous GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Fitch A., Ingersoll A.B

We prefer oral or SC routes rather than IV drips because IVs can be unpredictable in the clinic and expensive

Along with this, the market is estimated to grow at a CAGR of around 3.66% during the forecast period, i.e., 2026-32

Older participants occasionally took longer to reach full appetite suppression, but their 12-week weight loss percentages were comparable to younger participants

From managing stress